Anthony Santos, NP
Adult Health · Houston, TXNPI 1750610168
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,167 of the $12,753 with a category attached, or 64.0%. 18 manufacturers reported payments, led by Gilead at 46.1% of the total. 2025 is the largest year on record at $6,633, 4.9 times the $1,360 reported in 2021. Among adult health clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 374 payments — averaging $34.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$6K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Intercept Pharmaceuticals, Inc.$2K
- AbbVie$1K
- Ipsen Biopharmaceuticals, Inc$625
- Madrigal Pharmaceuticals$564
- plus $934 from 12 others
What the payments were for
- Consulting fees$7606%
- Speaking & faculty fees$2,88023%
- Travel & lodging$9467%
- Food & beverage$8,16764%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 81 | $5,885 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 126 | $2,123 |
| Intercept Pharmaceuticals, Inc. | 27 | $1,575 |
| AbbVie | 55 | $1,047 |
| Ipsen Biopharmaceuticals, Inc | 28 | $625 |
| Madrigal Pharmaceuticals | 27 | $564 |
| Novo Nordisk | 10 | $204 |
| Albireo Pharma, Inc. | 1 | $150 |
| Intra-sana Laboratories | 1 | $139 |
| Orphalan Inc | 5 | $136 |
| Fujifilm Healthcare Americas Corporation | 2 | $73 |
| Eisai Inc. | 2 | $57 |
| Exact Sciences | 2 | $39 |
| Ardelyx, Inc. | 2 | $35 |
| Ultragenyx Pharmaceutical Inc. | 2 | $35 |
| Boehringer Ingelheim | 1 | $30 |
| VBI Vaccine (delaware) Inc. | 1 | $19 |
| Kamada Ltd. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Livdelzi$3,951
- OCALIVA$1,079
- Bylvay$150
- Reltone 200 Mg$139
- Reltone 400 Mg$139
How this compares
$12,753 in reported general payments places this provider in the 95th percentile of 933 adult health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult health in Houston
- Kacey LyonsHouston$20K
- Rosa RancesHouston$17K
- Claressa RosacinaHouston$17K
- Michelle MartinHouston$15K
- Loren SemonesHouston$14K
- Dashawn ThomasHouston$11K
- Zandra RiveraHouston$11K
- Brandy KhodrHouston$10K
- Janice TranHouston$10K
- Ester CerdanHouston$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.